Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Spectragenetics in January, 2020 for $431,799.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44MH122115-01 | Phase I | 431,799 | January 1, 2020 | |||||||
A STTR Phase I contract was awarded to Spectragenetics in April, 2021 for $222,717.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA257114-01 | Phase I | 222,717 | April 7, 2021 | |||||||
A SBIR Phase II contract was awarded to Spectragenetics in March, 2022 for $711,325.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44MH122115-03 | Phase II | 711,325 | March 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Spectragenetics in September, 2016 for $444,284.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH111295-01 | Phase I | 444,284 | September 16, 2016 | |||||||
A SBIR Phase II contract was awarded to Spectragenetics for $947,753.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM060876-02 | Phase II | 947,753 | ||||||||
A SBIR Phase II contract was awarded to Spectragenetics for $1,228,120.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA108390-02A1 | Phase II | 1,228,120 | ||||||||
A SBIR Phase I contract was awarded to Spectragenetics for $99,671.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA108390-01 | Phase I | 99,671 | ||||||||
A SBIR Phase I contract was awarded to Spectragenetics for $99,966.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA110544-01 | Phase I | 99,966 | ||||||||
A SBIR Phase I contract was awarded to Spectragenetics from the U.S. Department of Health & Human Services. | SBIR | 2R44GM060876-02 | Phase I | 0 |